Overview
Paul Swiecicki is an Oncologist and a Hematologist in Ann Arbor, Michigan. Dr. Swiecicki is rated as an Experienced provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Squamous Cell Carcinoma. Dr. Swiecicki is currently accepting new patients.
His clinical research consists of co-authoring 90 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 5 articles in the study of Primary Amyloidosis.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
1500 E Medical Ctr, Suite 0331, Ann Arbor, MI 48109
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
University Physician Group
Jeffrey Zonder is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Zonder is rated as an Elite provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Multiple Myeloma, Primary Amyloidosis, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Vertebroplasty. Dr. Zonder is currently accepting new patients.
Regents Of The University Of Michigan
Erica Campagnaro is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Campagnaro is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is currently accepting new patients.
University Physician Group
Andrew Kin is a Hematologist and a Hematologist Oncology provider in Detroit, Michigan. Dr. Kin is rated as a Distinguished provider by MediFind in the treatment of Primary Amyloidosis. His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Sickle Cell Disease, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant. Dr. Kin is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Laryngeal CancerDr. Swiecicki isElite. Learn about Laryngeal Cancer.
- Throat CancerDr. Swiecicki isElite. Learn about Throat Cancer.
- Distinguished
- Head and Neck Squamous Cell Carcinoma (HNSCC)Dr. Swiecicki isDistinguished. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).
- Oral Squamous Cell CarcinomaDr. Swiecicki isDistinguished. Learn about Oral Squamous Cell Carcinoma.
- Advanced
- Acinic Cell Carcinoma of Salivary Glands
- Adenoid Cystic CarcinomaDr. Swiecicki isAdvanced. Learn about Adenoid Cystic Carcinoma.
- Epithelial-Myoepithelial CarcinomaDr. Swiecicki isAdvanced. Learn about Epithelial-Myoepithelial Carcinoma.
- GliomaDr. Swiecicki isAdvanced. Learn about Glioma.
- Nasopharyngeal CarcinomaDr. Swiecicki isAdvanced. Learn about Nasopharyngeal Carcinoma.
- Olfactory NeuroblastomaDr. Swiecicki isAdvanced. Learn about Olfactory Neuroblastoma.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Swiecicki isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Swiecicki isExperienced. Learn about Anemia.
- Basal Cell Skin CancerDr. Swiecicki isExperienced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Swiecicki isExperienced. Learn about Bone Tumor.
- Cardiac AmyloidosisDr. Swiecicki isExperienced. Learn about Cardiac Amyloidosis.
- Chromophobe Renal Cell CarcinomaDr. Swiecicki isExperienced. Learn about Chromophobe Renal Cell Carcinoma.